nodes	percent_of_prediction	percent_of_DWPC	metapath
Allylestrenol—CYP3A4—type 2 diabetes mellitus	0.447	1	CbGaD
Allylestrenol—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0715	0.152	CbGbCtD
Allylestrenol—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0637	0.136	CbGbCtD
Allylestrenol—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0583	0.124	CbGbCtD
Allylestrenol—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0509	0.109	CbGbCtD
Allylestrenol—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0461	0.0982	CbGbCtD
Allylestrenol—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0349	0.0744	CbGbCtD
Allylestrenol—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0335	0.0713	CbGbCtD
Allylestrenol—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0335	0.0713	CbGbCtD
Allylestrenol—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0316	0.0675	CbGbCtD
Allylestrenol—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0236	0.0503	CbGbCtD
Allylestrenol—CYP3A4—Losartan—type 2 diabetes mellitus	0.0216	0.046	CbGbCtD
Allylestrenol—Levonorgestrel—SRD5A1—type 2 diabetes mellitus	0.00177	0.216	CrCbGaD
Allylestrenol—Oxandrolone—AR—type 2 diabetes mellitus	0.00134	0.162	CrCbGaD
Allylestrenol—Desogestrel—SHBG—type 2 diabetes mellitus	0.00105	0.128	CrCbGaD
Allylestrenol—Norgestimate—ABCC2—type 2 diabetes mellitus	0.000765	0.0931	CrCbGaD
Allylestrenol—Levonorgestrel—SHBG—type 2 diabetes mellitus	0.000601	0.073	CrCbGaD
Allylestrenol—Levonorgestrel—AR—type 2 diabetes mellitus	0.000527	0.0641	CrCbGaD
Allylestrenol—Norethindrone—SHBG—type 2 diabetes mellitus	0.000487	0.0592	CrCbGaD
Allylestrenol—Methyltestosterone—SHBG—type 2 diabetes mellitus	0.000462	0.0562	CrCbGaD
Allylestrenol—Methyltestosterone—AR—type 2 diabetes mellitus	0.000405	0.0493	CrCbGaD
Allylestrenol—Levonorgestrel—CYP3A4—type 2 diabetes mellitus	0.000207	0.0252	CrCbGaD
Allylestrenol—Norethindrone—CYP3A4—type 2 diabetes mellitus	0.000168	0.0204	CrCbGaD
Allylestrenol—Methyltestosterone—CYP3A4—type 2 diabetes mellitus	0.000159	0.0194	CrCbGaD
Allylestrenol—Norethindrone—ALB—type 2 diabetes mellitus	0.000146	0.0178	CrCbGaD
Allylestrenol—Methyltestosterone—ALB—type 2 diabetes mellitus	0.000139	0.0169	CrCbGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	5.58e-05	0.000733	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	5.44e-05	0.000714	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GRK5—type 2 diabetes mellitus	5.33e-05	0.0007	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GIPR—type 2 diabetes mellitus	5.33e-05	0.0007	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	5.27e-05	0.000692	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—CDKN2B—type 2 diabetes mellitus	5.26e-05	0.00069	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	5.22e-05	0.000685	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—SIRT1—type 2 diabetes mellitus	5.2e-05	0.000683	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IAPP—type 2 diabetes mellitus	5.18e-05	0.000681	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—INSR—type 2 diabetes mellitus	5.15e-05	0.000677	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TRPC6—type 2 diabetes mellitus	5.06e-05	0.000665	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—AGTR2—type 2 diabetes mellitus	5.03e-05	0.000661	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	4.99e-05	0.000655	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	4.89e-05	0.000642	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MC4R—type 2 diabetes mellitus	4.88e-05	0.00064	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—HNF4A—type 2 diabetes mellitus	4.83e-05	0.000634	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—EDNRB—type 2 diabetes mellitus	4.82e-05	0.000633	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GIP—type 2 diabetes mellitus	4.69e-05	0.000616	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PSMD6—type 2 diabetes mellitus	4.68e-05	0.000614	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—HTR2C—type 2 diabetes mellitus	4.68e-05	0.000614	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	4.66e-05	0.000612	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—NR3C1—type 2 diabetes mellitus	4.62e-05	0.000606	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—PPP2CA—type 2 diabetes mellitus	4.59e-05	0.000603	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—EDNRA—type 2 diabetes mellitus	4.55e-05	0.000598	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CYBA—type 2 diabetes mellitus	4.53e-05	0.000595	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—IL6—type 2 diabetes mellitus	4.51e-05	0.000593	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—LEPR—type 2 diabetes mellitus	4.46e-05	0.000585	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	4.45e-05	0.000585	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—GHRL—type 2 diabetes mellitus	4.44e-05	0.000582	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PLAT—type 2 diabetes mellitus	4.44e-05	0.000582	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CALCA—type 2 diabetes mellitus	4.38e-05	0.000575	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	4.36e-05	0.000572	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	4.34e-05	0.00057	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—PPARA—type 2 diabetes mellitus	4.32e-05	0.000568	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	4.28e-05	0.000562	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	4.26e-05	0.00056	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—PSMD6—type 2 diabetes mellitus	4.22e-05	0.000555	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—DNMT1—type 2 diabetes mellitus	4.22e-05	0.000555	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	4.19e-05	0.00055	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—AKT1—type 2 diabetes mellitus	4.16e-05	0.000547	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—CTGF—type 2 diabetes mellitus	4.15e-05	0.000544	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TLE4—type 2 diabetes mellitus	4.15e-05	0.000544	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.13e-05	0.000542	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.06e-05	0.000533	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—GCG—type 2 diabetes mellitus	4.06e-05	0.000533	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.99e-05	0.000524	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	3.99e-05	0.000524	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.98e-05	0.000522	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	3.93e-05	0.000515	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	3.85e-05	0.000506	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—NOTCH2—type 2 diabetes mellitus	3.59e-05	0.000472	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—PPARG—type 2 diabetes mellitus	3.57e-05	0.000469	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	3.56e-05	0.000467	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.53e-05	0.000463	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	3.52e-05	0.000463	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	3.52e-05	0.000463	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.5e-05	0.000459	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	3.47e-05	0.000455	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—AVP—type 2 diabetes mellitus	3.45e-05	0.000453	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.45e-05	0.000453	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	3.44e-05	0.000451	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—RBP4—type 2 diabetes mellitus	3.44e-05	0.000451	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.43e-05	0.000451	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.42e-05	0.000449	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	3.38e-05	0.000444	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—AR—type 2 diabetes mellitus	3.35e-05	0.00044	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—APOB—type 2 diabetes mellitus	3.33e-05	0.000438	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.32e-05	0.000436	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	3.31e-05	0.000434	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.28e-05	0.000431	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—SERPINE1—type 2 diabetes mellitus	3.22e-05	0.000423	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—LPL—type 2 diabetes mellitus	3.18e-05	0.000418	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.12e-05	0.000409	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—CDKN2B—type 2 diabetes mellitus	3.09e-05	0.000405	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	3.06e-05	0.000402	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—SIRT1—type 2 diabetes mellitus	3.05e-05	0.000401	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.04e-05	0.0004	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—INSR—type 2 diabetes mellitus	3.02e-05	0.000397	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.99e-05	0.000392	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	2.97e-05	0.00039	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	2.95e-05	0.000388	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.93e-05	0.000385	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	2.89e-05	0.00038	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	2.89e-05	0.00038	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—C3—type 2 diabetes mellitus	2.87e-05	0.000376	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	2.83e-05	0.000371	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2.75e-05	0.000361	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	2.75e-05	0.000361	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	2.74e-05	0.00036	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	2.74e-05	0.00036	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.73e-05	0.000359	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.73e-05	0.000358	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—AGT—type 2 diabetes mellitus	2.72e-05	0.000358	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—NR3C1—type 2 diabetes mellitus	2.71e-05	0.000356	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—PPP2CA—type 2 diabetes mellitus	2.7e-05	0.000354	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.68e-05	0.000352	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.67e-05	0.000351	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—LEP—type 2 diabetes mellitus	2.67e-05	0.00035	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—APOE—type 2 diabetes mellitus	2.67e-05	0.00035	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.66e-05	0.000349	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.64e-05	0.000346	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	2.62e-05	0.000343	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.61e-05	0.000343	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.6e-05	0.000342	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.6e-05	0.000342	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.57e-05	0.000338	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—PPARA—type 2 diabetes mellitus	2.54e-05	0.000333	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.52e-05	0.00033	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.42e-05	0.000318	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	2.41e-05	0.000317	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	2.41e-05	0.000317	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GCG—type 2 diabetes mellitus	2.38e-05	0.000313	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.38e-05	0.000313	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.38e-05	0.000313	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.34e-05	0.000308	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.33e-05	0.000307	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	2.33e-05	0.000306	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.33e-05	0.000306	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	2.33e-05	0.000306	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	2.33e-05	0.000306	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	2.33e-05	0.000306	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—INS—type 2 diabetes mellitus	2.28e-05	0.000299	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	2.26e-05	0.000296	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.24e-05	0.000294	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.2e-05	0.00029	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.2e-05	0.000289	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	2.13e-05	0.00028	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	2.13e-05	0.00028	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—PPARG—type 2 diabetes mellitus	2.1e-05	0.000275	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.09e-05	0.000275	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	2.08e-05	0.000273	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.07e-05	0.000272	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.05e-05	0.000269	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AVP—type 2 diabetes mellitus	2.02e-05	0.000266	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.02e-05	0.000266	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.02e-05	0.000265	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.01e-05	0.000263	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—NOS3—type 2 diabetes mellitus	2e-05	0.000262	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2e-05	0.000262	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.98e-05	0.00026	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.98e-05	0.00026	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.98e-05	0.00026	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.96e-05	0.000257	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.95e-05	0.000256	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.93e-05	0.000253	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.9e-05	0.00025	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.9e-05	0.00025	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.89e-05	0.000248	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—RELA—type 2 diabetes mellitus	1.88e-05	0.000247	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.87e-05	0.000245	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.83e-05	0.00024	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.83e-05	0.00024	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.83e-05	0.00024	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.8e-05	0.000236	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.77e-05	0.000232	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.77e-05	0.000232	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.77e-05	0.000232	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.75e-05	0.00023	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.72e-05	0.000226	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.7e-05	0.000223	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—C3—type 2 diabetes mellitus	1.68e-05	0.000221	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.66e-05	0.000218	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.6e-05	0.000211	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.6e-05	0.000211	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.6e-05	0.00021	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.6e-05	0.00021	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.59e-05	0.000208	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.57e-05	0.000206	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.57e-05	0.000206	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.57e-05	0.000206	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.56e-05	0.000204	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.55e-05	0.000203	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.5e-05	0.000197	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.5e-05	0.000197	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.5e-05	0.000197	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.5e-05	0.000197	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—SRC—type 2 diabetes mellitus	1.48e-05	0.000194	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.48e-05	0.000194	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.44e-05	0.000189	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.44e-05	0.000189	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—AKT1—type 2 diabetes mellitus	1.41e-05	0.000186	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.4e-05	0.000183	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	1.34e-05	0.000176	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—INS—type 2 diabetes mellitus	1.34e-05	0.000176	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.32e-05	0.000174	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.32e-05	0.000173	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.3e-05	0.00017	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.29e-05	0.00017	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.29e-05	0.00017	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.25e-05	0.000164	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.23e-05	0.000161	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.22e-05	0.000161	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.22e-05	0.000161	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.2e-05	0.000158	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.19e-05	0.000157	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.19e-05	0.000157	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.19e-05	0.000157	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.19e-05	0.000156	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.17e-05	0.000154	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.17e-05	0.000154	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.16e-05	0.000153	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.15e-05	0.000151	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.1e-05	0.000145	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.07e-05	0.000141	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.07e-05	0.000141	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.07e-05	0.000141	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.05e-05	0.000138	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.04e-05	0.000137	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.02e-05	0.000134	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.96e-06	0.000131	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IL6—type 2 diabetes mellitus	9.96e-06	0.000131	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	9.79e-06	0.000129	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	9.68e-06	0.000127	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	9.68e-06	0.000127	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.41e-06	0.000124	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.31e-06	0.000122	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	9.28e-06	0.000122	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	9.28e-06	0.000122	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.19e-06	0.000121	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SRC—type 2 diabetes mellitus	8.68e-06	0.000114	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.45e-06	0.000111	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—AKT1—type 2 diabetes mellitus	8.3e-06	0.000109	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	8e-06	0.000105	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	8e-06	0.000105	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	7.96e-06	0.000105	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	7.86e-06	0.000103	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.76e-06	0.000102	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	7.63e-06	0.0001	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.61e-06	9.99e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	7.42e-06	9.74e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	7.28e-06	9.56e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	7.13e-06	9.36e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	7.11e-06	9.33e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	6.92e-06	9.09e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	6.83e-06	8.97e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	6.56e-06	8.61e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	6.43e-06	8.45e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	6.23e-06	8.18e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	6.13e-06	8.04e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	6.11e-06	8.02e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	6.04e-06	7.92e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.85e-06	7.68e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.39e-06	7.08e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	5.32e-06	6.98e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	5.22e-06	6.85e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	4.78e-06	6.28e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	4.57e-06	6.01e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	4.57e-06	6.01e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	4.18e-06	5.49e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.1e-06	2.76e-05	CbGpPWpGaD
